Delivery Order SPE2DB20D7059-SPE2DB25FPWK9

Award Date 12/12/24
Potential Completion Date 12/13/24
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB25FPWK9
    Delivery Order

This federal contract award is for the delivery of MENQUADFI VIAL 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $2,903.08, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 12, 2024 with a completion date of December 13, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type.

AmerisourceBergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies. This contract award is not designated as a set-aside and represents open competition.

Generated 3/13/25, 10:02 AM